These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12230710)

  • 41. [Symptomatic therapy of Alzheimer dementia].
    Förstl H
    Wien Med Wochenschr; 2002; 152(3-4):77-80. PubMed ID: 11925776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract]   [Full Text] [Related]  

  • 44. [Possibilities and limits of therapy of cognition disorders in the elderly].
    Hoyer S
    Z Gerontol Geriatr; 1995; 28(6):457-62. PubMed ID: 8581765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [When should the medication for dementia be stopped?].
    Pitkälä K
    Duodecim; 2003; 119(9):817-8. PubMed ID: 12815978
    [No Abstract]   [Full Text] [Related]  

  • 46. Memantine (Ebixa) in clinical practice - results of an observational study.
    Calabrese P; Essner U; Forstl H
    Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of neuropsychological tests in the Cronos Project].
    Bianchi G; Gasparini M; Caffari B; Sorrentino GC; Bianchi C; Bruno G; Maggini M; Raschetti R; Vanacore N
    Ann Ist Super Sanita; 2005; 41(1):69-74. PubMed ID: 16037653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dementias: mostly clinico-neuropsychological or mostly psychometric diagnosis?].
    Spinnler H
    Ann Ist Super Sanita; 2005; 41(1):75-80. PubMed ID: 16037654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Variability of efficacy measures in Alzheimer's disease].
    Musicco M; Pettenati C; Caltagirone C
    Ann Ist Super Sanita; 2005; 41(1):87-91. PubMed ID: 16037656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacological treatment in severe dementia].
    Jouanny P; Belliard S; Bentué-Ferrer D; Michel O; Allain H
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 53. Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
    Harvey RJ; Sciulli CG; Mason RM; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():29-32. PubMed ID: 9305512
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frontotemporal dementias: clinical features and management.
    Chow TW
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):58-70. PubMed ID: 12567333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen as a psychotherapeutic agent.
    Rodriguez MM; Grossberg GT
    Clin Geriatr Med; 1998 Feb; 14(1):177-89. PubMed ID: 9456341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measuring quality of life in dementia: purposes, goals, challenges and progress.
    Rabins PV; Black BS
    Int Psychogeriatr; 2007 Jun; 19(3):401-7. PubMed ID: 17346364
    [No Abstract]   [Full Text] [Related]  

  • 58. [Nootropic drug evaluation for general practice].
    Ihl R; Kretschmar C
    Nervenarzt; 1997 Nov; 68(11):853-61. PubMed ID: 9732727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy in Alzheimer disease].
    Kovács T
    Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
    [No Abstract]   [Full Text] [Related]  

  • 60. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.